Determination of the level of interleukin 6 in pregnant women with preeclampsia

Introduction: Pre-eclampsia represents a potentially life-threatening condition during pregnancy that significantly contributes to maternal and neonatal morbidity and mortality. Numerous studies within the fields of obstetrics and gynecology have documented elevated concentrations of interleukin-6 (IL-6) in women diagnosed with preeclampsia, suggesting that this cytokine may play a critical role in the pathophysiological mechanisms underlying the hypertension associated with this condition. Objectives: The aim of this investigation was to conduct a case-control study aimed at comparing the levels of IL-6 between pregnant women diagnosed with preeclampsia and those with normal pregnancies, in order to ascertain the presence of elevated IL-6 levels among the former group. Patients and Methods: This case-control study comprised 384 pregnant women at a gestational age exceeding 20 weeks, who were already diagnosed as preeclamptic and designated as cases, alongside a control group of 384 women devoid of any signs of hypertension or proteinuria during their pregnancies, matched for maternal age, body mass index (BMI), and gestational age. For all participants, IL-6 levels were quantified using an enzyme-linked immunosorbent assay (ELISA) that employs the Sandwich-ELISA methodology for the in vitro determination of human IL-6 concentrations in serum. Additionally, hemoglobin concentration, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), white blood cell (WBC) count, and platelets count were assessed utilizing a hematology analyzer based on the Coulter Principle. Furthermore, age, body mass index, gestational age, systolic blood pressure, and diastolic blood pressure were meticulously recorded. Results: Our findings revealed a statistically significant elevation in the levels of IL-6 among pregnant women with preeclampsia compared to those with normal pregnancy (P<0.001). Moreover, IL-6 exhibited a positive correlation with diastolic blood pressure (P=0.001). Conclusion: Our study indicates that IL-6 levels are markedly elevated during pregnancy in women diagnosed with preeclampsia.

Authors

Institutions

Publication Details

Journal
Journal of Nephropathology
Published
2025-04-06
DOI
https://doi.org/10.34172/jnp.2025.27582
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Determination of the level of interleukin 6 in pregnant women with preeclampsia

Falah H. Abdullah, Zainelabedeen Hasan Abed, Marwa Jasim Abdulqader, Sarah Jabbar Al Saidy
Journal of Nephropathology
Pregnancy and preeclampsia studies
article

Determination of the level of interleukin 6 in pregnant women with preeclampsia

Falah H. Abdullah, Zainelabedeen Hasan Abed, Marwa Jasim Abdulqader, Sarah Jabbar Al Saidy
article en

Abstract

Introduction: Pre-eclampsia represents a potentially life-threatening condition during pregnancy that significantly contributes to maternal and neonatal morbidity and mortality. Numerous studies within the fields of obstetrics and gynecology have documented elevated concentrations of interleukin-6 (IL-6) in women diagnosed with preeclampsia, suggesting that this cytokine may play a critical role in the pathophysiological mechanisms underlying the hypertension associated with this condition. Objectives: The aim of this investigation was to conduct a case-control study aimed at comparing the levels of IL-6 between pregnant women diagnosed with preeclampsia and those with normal pregnancies, in order to ascertain the presence of elevated IL-6 levels among the former group. Patients and Methods: This case-control study comprised 384 pregnant women at a gestational age exceeding 20 weeks, who were already diagnosed as preeclamptic and designated as cases, alongside a control group of 384 women devoid of any signs of hypertension or proteinuria during their pregnancies, matched for maternal age, body mass index (BMI), and gestational age. For all participants, IL-6 levels were quantified using an enzyme-linked immunosorbent assay (ELISA) that employs the Sandwich-ELISA methodology for the in vitro determination of human IL-6 concentrations in serum. Additionally, hemoglobin concentration, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), white blood cell (WBC) count, and platelets count were assessed utilizing a hematology analyzer based on the Coulter Principle. Furthermore, age, body mass index, gestational age, systolic blood pressure, and diastolic blood pressure were meticulously recorded. Results: Our findings revealed a statistically significant elevation in the levels of IL-6 among pregnant women with preeclampsia compared to those with normal pregnancy (P<0.001). Moreover, IL-6 exhibited a positive correlation with diastolic blood pressure (P=0.001). Conclusion: Our study indicates that IL-6 levels are markedly elevated during pregnancy in women diagnosed with preeclampsia.

Journal of NephropathologyVol. 14
University of Basrah (IQ), Thi Qar University (IQ), National University of Science and Technology (ZW)
Openalex Percentile: Top 72%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.